Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta‐analysis
Authors:
Open Access
- 2 June 2017
- journal article
- research article
- Published by Wiley in Colorectal Disease
- Vol. 19 (6) , 528-536
Abstract
Aim: Lynch syndrome (LS) accounts for 2–4% of all colorectal cancer (CRC) cases, and is associated with an increased risk of developing metachronous colorectal cancer (mCRC). The role of extended colectomy in LS CRC is controversial. There are limited studies comparing the risk of mCRC following segmental colectomy and extended colectomy. The objective of this systematic review is to evaluate the risk of developing mCRC following segmental and extended colectomy for LS CRC and endoscopic compliance.Method: A systematic review of major databases was performed using predefined terms. All original articles published in English comparing the risk of mCRC in LS patients after segmental and extended colectomy from 1950 to January 2016 were included.Results: The search retrieved 324 studies. Six studies involving 871 patients met the inclusion criteria. Of these, 705 (80.9%) underwent segmental colectomy and 166 (19.1%) extended colectomy. Average follow‐up was 91.2 months. The mCRC rate was 22.8% and 6% in the segmental and extended colectomy groups, respectively. The segmental group were over four times more likely to develop mCRC (OR 4.02, 95% CI: 2.01–8.04, P < 0.0001). mCRC occurred in patients after segmental colectomy despite 1–2‐yearly postoperative endoscopic surveillance.Conclusion: This result suggests that extended colectomy reduces the risk of mCRC by over four‐fold compared with segmental colectomy. mCRC occurred in the segmental group despite postoperative endoscopic surveillance. This needs to be borne in mind when deciding on the appropriate surgical management of LS patients with CRC. We recommend that extended colectomy should be considered for patients with confirmed LS CRC.Keywords
This publication has 29 references indexed in Scilit:
- ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer SyndromesAmerican Journal of Gastroenterology, 2015
- Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsGut, 2013
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgeryGut, 2010
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- Recommendations to improve identification of hereditary and familial colorectal cancer in EuropeFamilial Cancer, 2009
- Cancer Risks For Mismatch Repair Gene Mutation Carriers: A Population-Based Early Onset Case-Family StudyClinical Gastroenterology and Hepatology, 2006
- Surveillance for Hereditary Nonpolyposis Colorectal CancerDiseases of the Colon & Rectum, 2002
- Cancer risk in mutation carriers of DNA-mismatch-repair genesInternational Journal of Cancer, 1999
- Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II)Cancer Genetics and Cytogenetics, 1991